Evidence map›Paper›PMID 36053919›Full record

Observational studyArthritis & rheumatology (Hoboken, N.J.)2023

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis Registry.

Rouhin Sen, Emmeline Kim, Ruth J Napier, Elizabeth Cheng, Andrea Fernandez, Evan S Manning, Eric R Anderson, Kyle D Maier, Mena Hashim, Gail S Kerr and 7 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. CARD9 in the pathogenesis of axial spondyloarthritis.Best practice & research. Clinical rheumatology · 2024
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

Rouhin SenRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.ORCID 0000-0002-3411-8379
Emmeline KimRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.
Ruth J NapierPortland VAMC and Oregon Health Sciences University, Portland.
Elizabeth ChengRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.
Andrea FernandezRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.
Evan S ManningRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.
Eric R AndersonAurora Rheumatology, Racine, Wisconsin.
Kyle D MaierSan Antonio Military Medical Center, San Antonio, Texas.
Mena HashimRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.
Gail S KerrGeorgetown University Hospital, Howard University Hospital, and Washington DC VAMC, Washington, DC.
Meika A FangWest Los Angeles VAMC, and David Geffen School of Medicine at UCLA, Los Angeles, California.
Jason K HouHouston VAMC and Baylor College of Medicine, Houston, Texas.
Elizabeth ChangPhoenix VAMC, Phoenix, Arizona.
Jessica A WalshSalt Lake City VAMC and University of Utah Hospital, Salt Lake City.ORCID 0000-0002-4563-0845
Siba P RaychadhuriSacramento VAMC and UC-Davis Health, Sacramento, California.
Andreas ReimoldDallas VAMC and University of Texas Southwestern Medical Center, Dallas.
Liron CaplanRocky Mountain Regional VAMC, and University of Colorado School of Medicine, Denver, Colorado.ORCID 0000-0002-2799-3036
Rocky Mountain MS Center · USAurora Health Care · USBaylor College of Medicine · USBrooke Army Medical Center · USDallas VA Medical Center · USGeorgetown University · USOregon Health & Science University · USPhoenix VA Health Care System · USSacramento VA Medical Center · USUniversity of Utah Hospital · USWest Los Angeles College · US

Funding

Research Training in Rheumatology INCLUDE Down Syndrome SupplementT32AR007534 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Kristine A. Kuhn · 1986 to 2026
$6.1M
Reprogramming T Cells in Rheumatoid ArthritisIK2BX004523 · VA · PORTLAND VA MEDICAL CENTER · PI NAPIER, RUTH · 2019 to 2023
–
BLRD VA IK2 BX004523NIAMS NIH HHS T32 AR007534
6 · The paper itself

Abstract

objectivesThis study was conducted to assess the utility of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting radiographic sacroiliitis and active disease in axial spondyloarthritis (SpA) and to explore the association between use of a tumor necrosis factor inhibitor (TNFi) and these laboratory values compared with traditional inflammatory markers.

methodsObservational data from the Program to Understand the Longterm Outcomes in Spondyloarthritis (PULSAR) registry were analyzed. We generated receiver operating characteristic curves to calculate laboratory cutoff values; we used these values in multivariable logistic regression models to identify associations with radiographically confirmed sacroiliitis and active disease. We also used logistic regression to determine the likelihood of elevated laboratory values after initiation of TNFi.

resultsMost study participants (n = 354) were White, male, and HLA-B27 positive. NLR (odds ratio [OR] 1.459, P = 0.034), PLR (OR 4.842, P < 0.001), erythrocyte sedimentation rate (OR 4.397, P < 0.001), and C-reactive protein (CRP) level (OR 2.911, P = 0.001) were independent predictors of radiographic sacroiliitis. Models that included PLR with traditional biomarkers performed better than those with traditional biomarkers alone. NLR (OR 6.931, P = 0.002) and CRP (OR 2.678, P = 0.004) were predictors of active disease, but the model that included both NLR and CRP performed better than CRP alone. TNFi use reduced the odds of elevated NLR (OR 0.172, P < 0.001), PLR (OR 0.073, P < 0.001), erythrocyte sedimentation rate (OR 0.319, P < 0.001), and CRP (OR 0.407, P < 0.001), but models that included NLR or PLR and traditional biomarkers performed best.

conclusionsThese findings demonstrate an association between NLR and PLR and sacroiliitis and disease activity, with NLR and PLR showing response after TNFi treatment and adding useful clinical information to established biomarkers, thus perhaps assisting in management of axial SpA.

Indexed as

Axial SpondyloarthritisSacroiliitisSpondylarthritisBiomarkersBlood PlateletsHumansLymphocytesMaleNeutrophilsRetrospective StudiesBiomarkers

Identifiers

PMID36053919
PMCPMC9892177
OpenAlexW4293109620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.